IRADIMED CORPORATION (IRMD) - רווח נקי למניה (EPS TTM)
The 12-month net income per share chart on the GURU.Markets platform demonstrates a trend where the value 1.86 expresses the state of the metric. IRADIMED CORPORATION (IRMD) dominates the MRI-compatible pump segment, expanding its global reach across clinics. Unique monitoring systems ensure patient safety and stable sales. The proprietary ecosystem and complex certification create high barriers for hospitals to switch to alternative solutions.
IRMD (IRADIMED Corp): פילוחים אנליטיים ודוחות לפי אינדיקטורים
An analysis of the trailing twelve-month net income per share confirms IRADIMED CORPORATION (IRMD) as a monopolist in the MRI-compatible pump segment, granting it significant pricing power. The current value of 1.86 reflects the rolling annual profit divided by the number of shares, allowing investors to assess the actual capitalization efficiency and the resilience of the business model regardless of short-term market fluctuations.
